Characteristics of Hospice and Palliative Care Programs in US Prisons: An Update and 5-Year Reflection

被引:13
作者
Prost, Stephanie Grace [1 ]
Holland, Margaret M. [2 ]
Hoffmann, Heath C. [3 ]
Dickinson, George E. [3 ]
机构
[1] Univ Louisville, Raymond A Kent Sch Social Work, Louisville, KY 40292 USA
[2] Florida State Univ, Coll Social Work, Tallahassee, FL 32306 USA
[3] Coll Charleston, Dept Sociol & Anthropol, Charleston, SC 29401 USA
关键词
prison hospice; prison palliative care; peer caregivers; terminal illness; pain management; OF-LIFE CARE; SURVEY RESPONSE RATE; PAIN MANAGEMENT; HEALTH; GRIEF;
D O I
10.1177/1049909119893090
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Individuals with terminal illness are dying behind bars and many state prison administrators have incorporated on-site hospice and palliative care services. Little is known, however, about these programs since a 2010 study of prison hospice characteristics. We provide an updated description and reflection of current hospice and palliative care programs in state prisons serving incarcerated persons with terminal illness. A cross-sectional survey was sent to representatives of all known prisons offering hospice and palliative care programs and services (N = 113). Questions were drawn from an earlier iteration regarding interdisciplinary team (IDT) membership, training length and topics, peer caregivers, visitation policies, bereavement services, perceived stakeholder support, and pain management strategies. Additional questions were added such as estimated operational costs, peer caregiver input in patient care, and the strengths and weaknesses of such programs. Frequency distributions were calculated for all study variables. Responding representatives (n = 33) indicated IDTs remain integral to care, peer caregivers continue to support dying patients, and perceived public support for these programs remains low. Reduced enthusiasm for the programs may negatively influence administrative decision-making and program resources. Further, peer caregiver roles appear to be changing with caregivers charged with fewer of the identified tasks, compared with the 2010 study.
引用
收藏
页码:514 / 520
页数:7
相关论文
共 27 条
  • [21] Creating a Sustainable Foundation for IR Services and Training in Sub-Saharan Africa: 5-Year Update on the Road2IR Initiative
    Alswang, Jared M.
    Mbuguje, Erick M.
    Chan, Shin Mei
    Ak, Murat
    Naif, Azza
    Rukundo, Ivan
    Minja, Frank
    Newsome, Janice
    Ramalingam, Vijay
    Gaupp, Fabian M. Laage
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2024, 35 (07) : 1049 - 1056
  • [22] Increasing Trend and Characteristics of Korean Adolescents Presenting to Emergency Department for Self-Harm: A 5-Year Experience, 2015 to 2019
    Cheon, Jooah
    Oh, Donghun
    Lee, Junghan
    Ahn, Jaeun
    Song, Dong-Ho
    Cheon, Keun-Ah
    YONSEI MEDICAL JOURNAL, 2020, 61 (07) : 614 - 622
  • [23] Implementing Evidence-Based Palliative Care Programs and Policy for Cancer Patients: Epidemiologic and Policy Implications of the 2016 American Society of Clinical Oncology Clinical Practice Guideline Update
    Isenberg, Sarina R.
    Aslakson, Rebecca A.
    Smith, Thomas J.
    EPIDEMIOLOGIC REVIEWS, 2017, 39 (01) : 123 - 131
  • [24] Mapping the Landscape of Advance Care Planning in Adolescents and Young Adults Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A 5-Year Retrospective Review
    Pennarola, Brian W.
    Fry, Abigail
    Prichett, Laura
    Beri, Andrea E.
    Shah, Nirali N.
    Wiener, Lori
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (03): : 164.e1 - 164.e8
  • [25] Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort study
    Bajpai, Ram
    Muller, Sara
    Mallen, Christian
    Watson, Lorraine
    Richette, Pascal
    Hider, Samantha L.
    Roddy, Edward
    RHEUMATOLOGY, 2022, 61 (01) : 407 - 412
  • [26] Lead exposure in young children over a 5-year period from urban environments using alternative exposure measures with the US EPA IEUBK model - A trial
    Gulson, Brian
    Taylor, Alan
    Stifelman, Marc
    ENVIRONMENTAL RESEARCH, 2018, 161 : 87 - 96
  • [27] Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
    Verstovsek, Srdan
    Mesa, Ruben A.
    Gotlib, Jason
    Gupta, Vikas
    DiPersio, John F.
    Catalano, John V.
    Deininger, Michael W. N.
    Miller, Carole B.
    Silver, Richard T.
    Talpaz, Moshe
    Winton, Elliott F.
    Harvey, Jimmie H., Jr.
    Arcasoy, Murat O.
    Hexner, Elizabeth O.
    Lyons, Roger M.
    Paquette, Ronald
    Raza, Azra
    Jones, Mark
    Kornacki, Deanna
    Sun, Kang
    Kantarjian, Hagop
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 14